Antiviral - Variola (Smallpox) Virus Treatment

The classification phrase "Antiviral - Variola (Smallpox) Virus Treatment" serves as an administrative and therapeutic category within compendia rather than a single pharmacologic mechanism class, encompassing antiviral agents indicated for human smallpox Approved under the Animal Rule because clinical trials in infected humans are neither ethical nor feasible, these agents include viral egress inhibitors like tecovirimat, which blocks the orthopoxvirus VP37 protein, and nucleotide analogs like ...

The classification phrase "Antiviral - Variola (Smallpox) Virus Treatment" serves as an administrative and therapeutic category within compendia rather than a single pharmacologic mechanism class, encompassing antiviral agents indicated for human smallpox

The classification phrase "Antiviral - Variola (Smallpox) Virus Treatment" serves as an administrative and therapeutic category within compendia rather than a single pharmacologic mechanism class, encompassing antiviral agents indicated for human smallpox Approved under the Animal Rule because clinical trials in infected humans are neither ethical nor feasible, these agents include viral egress inhibitors like tecovirimat, which blocks the orthopoxvirus VP37 protein, and nucleotide analogs like ...

Approved under the Animal Rule because clinical trials in infected humans are neither ethical nor feasible, these agents include viral egress inhibitors like tecovirimat, which blocks the orthopoxvirus VP37 protein, and nucleotide analogs like brincidofovir, which inhibits viral DNA polymerase

Approved under the Animal Rule because clinical trials in infected humans are neither ethical nor feasible, these agents include viral egress inhibitors like tecovirimat, which blocks the orthopoxvirus VP37 protein, and nucleotide analogs like brincidofovir, which inhibits viral DNA polymerase Primarily stockpiled as biodefense medical countermeasures for the treatment of smallpox disease caused by the variola virus, these therapeutics are also utilized under expanded-access or investigational p...

Primarily stockpiled as biodefense medical countermeasures for the treatment of smallpox disease caused by the variola virus, these therapeutics are also utilized under expanded-access or investigational protocols to manage other severe orthopoxvirus infections, such as mpox and vaccinia-related complications

Primarily stockpiled as biodefense medical countermeasures for the treatment of smallpox disease caused by the variola virus, these therapeutics are also utilized under expanded-access or investigational protocols to manage other severe orthopoxvirus infections, such as mpox and vaccinia-related complications

Primarily stockpiled as biodefense medical countermeasures for the treatment of smallpox disease caused by the variola virus, these therapeutics are also utilized under expanded-access or investigational protocols to manage other severe orthopoxvirus infections, such as mpox and vaccinia-related complications